Learn more

DR REDDY'S LABORATORIES LTD

Overview
  • Total Patents
    102
  • GoodIP Patent Rank
    17,836
  • Filing trend
    ⇩ 94.0%
About

DR REDDY'S LABORATORIES LTD has a total of 102 patent applications. It decreased the IP activity by 94.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are KALA PHARMACEUTICALS INC, COLBY PHARMACEUTICAL COMPANY and PHOTOCHEMICAL CO LTD.

Patent filings per year

Chart showing DR REDDY'S LABORATORIES LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Peddy Vishweshwar 16
#2 Raghuvanshi Rajeev Singh 16
#3 Padhi Bijay Kumar 11
#4 Sasmal Pradip Kumar 10
#5 Tehim Ashok 10
#6 Ahmed Shahadat 8
#7 Kandavilli Sateesh 8
#8 Okumu Franklin 8
#9 Dahanukar Vilas Hareshwar 7
#10 Ubaidulla Udhumansha 7

Latest patents

Publication Filing date Title
WO2020165807A1 Solid forms of deutetrabenazine and process for the preparation thereof
AU2019205134A1 Minocycline for treating inflammatory skin conditions
WO2018020417A1 Process for preparation of protein or peptide
WO2017221144A1 Process for the preparation of elagolix sodium and its polymorph
WO2017216761A1 Solid forms of entinostat
WO2017208069A2 Oral composition of celecoxib for treatment of pain
WO2017203474A1 Process for preparation of sacubutril intermediate
WO2017203457A1 Solid state forms of empagliflozin
WO2017134617A1 Process for the preparation of amorphous dasatinib
WO2017118940A1 Solid forms of selinexor and process for their preparation
WO2017118915A1 Amorphous and crystalline solid forms of lumacaftor or its complex and preparative processes thereof
WO2017115315A1 Solid forms of palbociclib
WO2017109761A1 Topical composition for the treatment of acne
WO2017093949A1 Substantially pure canagliflozin
WO2017064627A2 Process for preparation of eribulin and intermediates thereof
WO2017042683A1 Isolated intermediate of dapagliflozin, process for the preparation of isolated intermediate of dapagliflozin, process for the preparation of dapagliflozin
WO2017037596A1 Amorphous solid dispersion of lcz-696
WO2017029594A1 Processes for preparation of selexipag and its amorphous form
WO2017021871A1 A cell culture process for modulating glycans
WO2016207824A2 A stable pharmaceutical composition comprising ramipril and/or amlodipine